HCM
GH icon

Hollencrest Capital Management’s Guardant Health GH Stock Holding History

Hollencrest Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-445
Closed -$41.1K – 1284
2026
Q1 		$41.1K Buy
+445
New +$44.7K ﹤0.01% 591
2025
Q2 		– Sell
-460
Closed -$19.6K – 1160
2025
Q1 		$19.6K Buy
+460
New +$19.8K ﹤0.01% 676

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Hollencrest Capital Management's GH Position: Q2 2026 in Review

Hollencrest Capital Management sold out of Guardant Health (GH) in Q2 2026, closing a stake of 445 shares — an estimated $41.1K sold.

Hollencrest Capital Management first reported a position in GH in Q1 2025 and held it in 2 quarters. The position peaked at $41.1K in Q1 2026. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Hollencrest Capital Management reported no remaining Guardant Health position as of Q2 2026 after selling out during the quarter.
  • Hollencrest Capital Management sold 445 Guardant Health shares in Q2 2026, an estimated $41.1K.
  • Hollencrest Capital Management first reported a position in Guardant Health in Q1 2025 and held it in 2 quarters.
  • Hollencrest Capital Management's Guardant Health position peaked at $41.1K in Q1 2026.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.